alcept 500 mycophenolate mofetil 500 mg film coated tablet blister
pharmacor pty ltd - mycophenolate mofetil, quantity: 500 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; povidone; microcrystalline cellulose; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; iron oxide red; iron oxide black; macrogol 400 - mycophenolate mofetil is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants.,mycophenolate mofetil is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.
alcept mycophenolate mofetil 1g/5ml powder for oral suspension bottle pack
pharmacor pty ltd - mycophenolate mofetil, quantity: 200 mg/ml - suspension - excipient ingredients: lecithin; sodium citrate dihydrate; colloidal anhydrous silica; xanthan gum; methyl hydroxybenzoate; aspartame; sorbitol; citric acid; flavour - alcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants.,alcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.
mycocell mycophenolate mofetil 1g/5ml powder for oral suspension bottle pack
pharmacor pty ltd - mycophenolate mofetil, quantity: 200 mg/ml - suspension - excipient ingredients: sorbitol; sodium citrate dihydrate; citric acid; colloidal anhydrous silica; lecithin; aspartame; xanthan gum; methyl hydroxybenzoate; flavour - mycocell is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants.,mycocell is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.
pharmacor mycophenolate mycophenolate mofetil 1g/5ml powder for oral suspension bottle pack
pharmacor pty ltd - mycophenolate mofetil, quantity: 200 mg/ml - suspension - excipient ingredients: sorbitol; sodium citrate dihydrate; citric acid; methyl hydroxybenzoate; xanthan gum; aspartame; lecithin; colloidal anhydrous silica; flavour - pharmacor mycophenolate is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants.,pharmacor mycophenolate is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.
mycolat 250 mg hard capsules
rowex ltd - mycophenolate mofetil - capsule, hard - 250 milligram(s) - selective immunosuppressants; mycophenolic acid
mycolat 500 mg film-coated tablets
rowex ltd - mycophenolate mofetil - film-coated tablet - 500 milligram(s) - selective immunosuppressants; mycophenolic acid
mycophenolate mofetil 500mg film-coated tablets
wockhardt uk limited - mycophenolate mofetil - film-coated tablet - 500 milligram(s) - selective immunosuppressants; mycophenolic acid
mycophenolate mofetil 500mg film-coated tablets
accord healthcare limited - mycophenolate mofetil - film-coated tablet - 500 milligram(s) - selective immunosuppressants; mycophenolic acid
mycophenolate mofetil accord 250 mg capsules
accord healthcare limited - mycophenolate mofetil - capsule - 250 milligram(s) - selective immunosuppressants; mycophenolic acid
mycophenolate mofetil clonmel 250 mg capsules hard
clonmel healthcare ltd - mycophenolate mofetil - capsule, hard - 250 milligram(s) - selective immunosuppressants; mycophenolic acid